Tenax Therapeutics EBITDA Margin Growth & History (TENX)
Tenax Therapeutics's ebitda margin was −29,762.21% for fiscal 2015.
View full Tenax Therapeutics company overviewTenax Therapeutics annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2015 · Apr 30 | 2015-04-30 | −29,762.21% | −19404.79 pp |
| 2014 | 2014-04-30 | −10,357.42% | −9934.20 pp |
| 2013 | 2013-04-30 | −423.22% | +1779.62 pp |
| 2012 | 2012-04-30 | −2,202.84% | −12742.75 pp |
| 2011 | 2011-04-30 | 10,539.90% | — |
Tenax Therapeutics quarterly ebitda margin
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q3 2014 | 2014-01-31 | −5,721.14% | −5022.13 pp |
| Q2 2014 | 2013-10-31 | −3,727.77% | −3602.27 pp |
| Q1 2014 | 2013-07-31 | −936.23% | −334.11 pp |
| Q4 2013 | 2013-04-30 | −661.55% | +1248.21 pp |
| Q3 2013 | 2013-01-31 | −699.02% | +532.93 pp |
| Q2 2013 | 2012-10-31 | −125.50% | +2004.03 pp |
| Q1 2013 | 2012-07-31 | −602.12% | +8793.63 pp |
| Q4 2012 | 2012-04-30 | −1,909.76% | — |
| Q3 2012 | 2012-01-31 | −1,231.94% | −11834.35 pp |
| Q2 2012 | 2011-10-31 | −2,129.53% | −9923.66 pp |
| Q1 2012 | 2011-07-31 | −9,395.75% | — |
| Q3 2011 | 2011-01-31 | 10,602.41% | — |
| Q2 2011 | 2010-10-31 | 7,794.14% | — |
Tenax Therapeutics ebitda margin trends
Between the periods ended 2011-04-30 and 2015-04-30, Tenax Therapeutics's ebitda margin decreased from 10,539.90% to −29,762.21%, a change of −40302.11 percentage points. The latest reported quarter, Q3 2014, shows −5,721.14%.
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenax Therapeutics source filings ↗